加载中
NASDAQHealthcareMedical - Diagnostics & Research
最新数据
US$94.6525
+US$1.5825 · +1.70%
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
常规交易时段
US$94.32
+US$1.25 · +1.34%
盘中时间采用ET。市场数据可能有所延迟。
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
日内区间
当前US$94.32
52周区间
当前US$94.32
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
买入
估值
89
深度低估
情绪
51
多空交织
风险
38
中等风险
动量
75
动能增强
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
日内区间
当前US$94.32
52周区间
当前US$94.32
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 |
|---|---|---|---|
| 营收 | 3.05亿 USD | 1.53亿 USD | 7172.9万 USD |
| 销货成本 | 9665.4万 USD | 7166.7万 USD | 5442.1万 USD |
| 毛利 | 2.08亿 USD | 8091.5万 USD | 1730.8万 USD |
| 研究与开发 | 4938.4万 USD | 3659.6万 USD | 2241.4万 USD |
| 销售、一般及管理费用 | 1.43亿 USD | 9146.5万 USD | 6438.9万 USD |
| 营业费用 | 1.92亿 USD | 1.28亿 USD | 8680.3万 USD |
| 利息收入 | 775万 USD | 581.9万 USD | 345.6万 USD |
| 利息支出 | 9.5万 USD | 238.6万 USD | 327.2万 USD |
| 折旧和摊销 | 1190.7万 USD | 1168.8万 USD | 646.3万 USD |
| 营业利润 | 1602.3万 USD | −4714.6万 USD | −6949.5万 USD |
| 净利润 | 745.4万 USD | −4157万 USD | −8268.3万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$126
上涨空间 33.59%评级样本有限，仅4项
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI6580.92万0.00%2.3万亿 USD0.03%US$380.84-0.19%
Vanguard Morningstar Small-Cap ETFVB4751.72万0.03%1853亿 USD0.03%US$287.51-0.23%
Vanguard Morningstar Small-Cap Value ETFVBR1509.95万0.02%682亿 USD0.05%US$235.02+0.13%
Vanguard Morningstar Small-Cap Growth ETFVBK1361.13万0.03%447亿 USD0.05%US$338.2-0.79%
Schwab U.S. Small-Cap ETFSCHA1087.16万0.05%217.13亿 USD0.03%US$32.495-0.51%
F/M Emerald Life Sciences Innovation ETFLFSC508.19万4.31%1.16亿 USD0.79%US$41.24-1.88%
Vanguard Extended Market ETFVXF477.2万0.00%954亿 USD0.05%US$231.94-0.68%
iShares U.S. Healthcare Providers ETFIHF361.4万0.26%13.54亿 USD0.37%US$57.33+0.28%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRVanguard Morningstar Small-Cap Growth ETFVBKSchwab U.S. Small-Cap ETFSCHAF/M Emerald Life Sciences Innovation ETFLFSCVanguard Extended Market ETFVXFiShares U.S. Healthcare Providers ETFIHFAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
